Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

Brain Microenvironment Makes HER2-positive Breast Cancer Metastases Resistant to Treatment

(Mass General) May 24, 2017 - While target therapies directed toward genetic mutations that drive a tumor’s growth have significantly improved the outlook for many patients, they have not been as successful in controlling brain metastases in several types of cancer.

Study Shows Digitally Delivered Patient Education Improves IV Cancer Treatment Adherence and Patient Survival

(PRWeb) May 18, 2017 - Navigating Cancer, the leading patient relationship management technology provider in cancer care announced the release of a retrospective, multi-center study that shows significant improvement in IV treatment adherence and one year survival rates for lung cancer patients receiving and viewing a digital series of education about their treatment compared to patients who did not view treatment information.

FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications

(Pfizer) May 25, 2017 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval of the Company’s proposed epoetin alfa biosimilar across all indications.

Gut Bugs Signal Success of Bone Marrow Transplant

(MedPage Today) May 24, 2017 - Patients who harbored a certain kind of bacteria within their intestinal tract seemed to have a lower risk of seeing their hematologic malignancies return after allogeneic hematopoietic-cell transplantation (allo-HCT), researchers reported.

ASCO Launches CENTRA, a New Hub for Cancer Care Research, Data, and Analysis

(ASCO in Action) May 25, 2017 - Dr. Elizabeth Garrett-Mayer, nationally recognized biostatistician, appointed to lead CENTRA's biostatistics and data management efforts.

Possible Link Between Platelets and Cancer Risk, Though Further Work Needed

(Cancer Research UK/Press Association) May 25, 2017 - A possible link between cancer and the levels of a component of blood, called platelets, should be investigated further, according to a new study.

CancerLinQ LLC CEO to Join Oncology Leaders on Keynote Panel: Use CancerLinQ400 and Save $400 on Your Summit Pass

(ASCO in Action) May 23, 2017 - CancerLinQ, LLC CEO, Kevin Fitzpatrick will join leaders of the cancer community including the Cancer Support Community and the American Cancer Society in speaking at the 2017 eyeforpharma Oncology Market Access & Pricing, taking place in Philadelphia.

Do Men Have Worse Chemotherapy-Induced Cardiomyopathy Than Women?

(European Society of Cardiology) May 25, 2017 - Men seem to have worse chemotherapy-induced cardiomyopathy than women despite receiving similar cancer treatments, according to research presented today at EuroCMR 2017.

University of Kansas Cancer Center Partners with Dana-Farber Cancer Institute and the Leukemia & Lymphoma Society to Offer Innovative Blood Cancer Clinical Trials

(KU Medical Center) May 24, 2017 - The University of Kansas Cancer Center has announced that it will join a consortium with the Dana-Farber Cancer Institute, in collaboration with The Leukemia & Lymphoma Society (LLS), to bring clinical trials testing innovative blood cancer therapies to Kansas City.

Coffee Reduces Liver Cancer Risk: Five Cups a Day Linked to 50 Percent Drop in Hepatocellular Carcinoma

(Newsweek) May 25, 2017 - Scientists have discovered a link between drinking coffee regularly and a reduced risk of developing one of the most common types of liver cancer.